Literature DB >> 32608516

Gynecological surgeries during the COVID-19 pandemic in Turkey.

Esra Keles1, Serkan Akis1, Ugur Kemal Ozturk1, Sefik Eser Ozyurek1, Murat Api1.   

Abstract

Entities:  

Keywords:  2019-nCoV; COVID-19; Coronavirus; Gynecological oncology; SARS-CoV-2; Surgery

Year:  2020        PMID: 32608516      PMCID: PMC9087775          DOI: 10.1002/ijgo.13292

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   4.447


× No keyword cloud information.
Whilst urgent gynecological and oncologic operations have continued, the SARS‐CoV‐2 (COVID‐19) pandemic has impacted patient management through postponement of elective surgeries. , , , , Cohen et al. suggested that during the pandemic each patient should be evaluated individually with added measures for the protection of both the patient and healthcare professionals. Therefore, we conducted a study evaluating patients’ and hospital workers’ health status during the pandemic in Turkey. This prospective follow‐up study was a re‐examination of clinical and post‐discharge telephone call survey data of patients for whom major gynecological surgeries were performed at our hospital during the COVID‐19 pandemic between March 10 and April 20, 2020. Ethical approval for this study was provided by the Research Ethics Committee (2020/76) of The Zeynep Kamil Womenʼs and Childrenʼs Disease Training and Research Hospital, where COVID‐19 patients were not primarily treated. Informed consent was obtained from all patients. Statistical analyses were performed using SPSS version 20 (IBM, Armonk, NY, USA). Surgical attendants were protected with surgical masks, caps, gowns, sterile gloves, and face shields during surgery. The choice of surgical mask type and face shield was subject to the availability of equipment and discretion of the medical staff and surgeons. Only essential personnel remained in the operating room during patient intubation/extubation. Our hospital did not have a negative‐pressure operating theater, and a high‐efficiency particulate air filter was not available in the operating rooms. During the study period, 1515 surgical procedures were performed. After excluding ambulatory surgical procedures (Fig. 1), 141 operations remained to be analyzed. We managed to reach 127 (90%) of these patients within 14 postoperative days. Since none of the patients presented with COVID‐19 symptoms, reverse transcriptase‐polymerase chain reaction (RT‐PCR) and antibody testing had not been performed preoperatively. During telephone calls, patients were asked whether they had symptoms including fever or cough, and whether they had a positive COVID‐19 test following their surgery. The type of surgery, indications, pathological results, length of stay in intensive care unit and/or hospital, blood transfusions, and data including any symptoms/tests for COVID‐19 ( RT‐PCR testing, detection of SARS‐CoV‐2 antibodies, chest CT, etc.) obtained during the telephone conversations are presented in Table 1.
Figure 1

Flow diagram of the study.

Table 1

Surgical and clinical characteristics of the study population (N = 127).

Percentage (%)N (number)
Type of surgery
Abdominal approach67.786
Laparotomy (L/S)26.834
Laparoscopy (L/T)40.952
Vaginal approach32.341
Hysteroscopy15.019
Conization7.19
TOT or TVT4.76
VH1.62
Other3.95
Indications of operation
Emergency4.76
Ectopic pregnancy10.213
Adnexal mass20.526
Malignancy7.910
Myoma uteri10.213
Abnormal bleeding11.915
Cervical dysplasia8.711
Infertility10.213
Genital prolapse6.38
Urinary incontinence4.76
Other4.76
Pathology results
Benign85.8109
Malign14.218
Cervical cancer1.62
Endometrial cancer6.38
Ovarian cancer5.57
Borderline ovarian tumor0.81
Length of stay in hospital
≤1 day60.677
2 day18.123
3 day8.711
4 ≤ day12.616
Length of stay in ICU
None83.5106
1 day11.014
2 day5.57
Abdominal drainage
No63.881
Yes36.246
Blood transfusion
No87.4111
Yes12.616
Polyclinic visits
159.175
233.042
3≤7.910
Fever a
No97.6124
Yes2.43
Coughing a
No92.9118
Yes7.19
Covid‐19 testing a 3.14
Test positive and use of CT a 1.62

Abbreviations: CT, Computerized tomography; ICU, Intensive care unit; TOT, Transobturator tape; TVT, Tension‐free vaginal tape; VH, Vaginal hysterectomy.

After discharge.

Flow diagram of the study. Surgical and clinical characteristics of the study population (N = 127). Abbreviations: CT, Computerized tomography; ICU, Intensive care unit; TOT, Transobturator tape; TVT, Tension‐free vaginal tape; VH, Vaginal hysterectomy. After discharge. After discharge, fever was reported in three patients (2.4%) and cough in nine patients (7.1%). COVID‐19 tests were performed in two of the three patients with fever, and four of the nine patients with cough. In the postoperative period 1.6% (2/127) of all patients tested positive for COVID‐19. As the pandemic progressed, we found that the total number of surgeries decreased by 77.9%, and the number of oncologic surgeries decreased by 20% in the last 3 weeks of the study period. However, proportionally speaking, the ratio of malignant cases operated on at our hospital continued to increase in parallel with the increasing incidence of COVID‐19 and intensifying precautions (Table 2). The weekly proportion of malignant cases within the total number of major surgical interventions are presented in Figure 2. Nationwide COVID‐19 cases and all data from this study within 6‐week time segments are shown in Table 2.
Table 2

Clinical data of this study and COVID‐19 cases in Turkey over 6 weeks

1st Week2nd Week3rd Week4th Week5th Week6th Week
March 10–16March 17–23March 24–30March 31–April 6April 7–13April 14–20
Nationwide case a
New4714829298193903083229931
Total47152910827302176104990980
Active46149210497282425579675410
Nationwide death a
New136131481647844
Total13716864912962140
Nationwide recoveries a
New00162116426319473
Total001621326395713430
Surgical procedures b 72 (56.7)24 (18.9)8 (6.3)9 (7.1)6 (4.7)8 (6.3)
Laparoscopy28 (38.9)9 (37.5)4 (50.0)4 (44.4)1 (16.7)6 (75.0)
Laparotomy15 (20.8)3 (12.5)4 (50.0)5 (55.6)5 (83.3)2 (25.0)
Vaginal approach29 (40.3)12 (50.0)
Age c 41.0 (22–70)38.5 (20–81)41.5 (24–66)53.0 (30–70)42.0 (31–60)37.0 (23–48)
Pathology results b
Benign67 (93.1)22 (91.7)5 (62.5)4 (44.4)4 (66.7)7 (87.5)
Malign5 (6.9)2 (8.3)3 (37.5)5 (55.6)2 (33.3)1 (12.5)
Blood transfusion b 3 (4.2)1 (4.2)5 (62.5)3 (33.3)3 (50.0)1 (12.5)
Abdominal drain b 15 (20.8)6 (25.0)7 (87.5)8 (88.9)6 (100.0)4 (50.0)
Length of stay in hospital c 1.0 (0–13)1.0 (1–8)2.5 (1–7)4.0 (1–10)3.0 (2–5)2.0 (1–4)
Length of stay in ICU c 0.0 (0–2)0.0 (0–1)0.5 (0–2)1.0 (0–2)0.5 (0–1)0.0 (0–1)
Duration of surgery d 80 (10–270)60 (20–150)150 (60–210)180 (60–210)180 (60–180)90 (60–240)
Fewer a 3 (4.2)
Cough b 8 (11.1)1 (4.2)
COVID‐19 testing b 4 (5.6)
Use of CT and positive test a 2 (2.8)

Abbreviations: CT, Computerized Tomography; ICU, Intensive Care Unit.

Number (n).

n (percent [%]).

Median (Minimum[min]–Maximum[max]) (day).

Median (min–max) (minute).

Figure 2

Number of new COVID‐19 cases and surgeries in our institution.

Clinical data of this study and COVID‐19 cases in Turkey over 6 weeks Abbreviations: CT, Computerized Tomography; ICU, Intensive Care Unit. Number (n). n (percent [%]). Median (Minimum[min]–Maximum[max]) (day). Median (min–max) (minute). Number of new COVID‐19 cases and surgeries in our institution. During the COVID‐19 outbreak, all health institutions in our country were rearranged to serve patients who were diagnosed with or suspected of having COVID‐19 while scheduled elective surgeries were postponed. , Since our institution did not accept known or suspected cases of COVID‐19, we did not change our strategy in planning for gynecologic oncological surgeries. Therefore, due to additional referrals, we operated on a higher proportion of malignant surgical cases during the 6 week period. Despite postponing elective cases, we performed a considerable number of surgical procedures. Whilst 127 major gynecological surgical procedures were performed, two patients developed COVID‐19 symptoms following discharge. Meanwhile, eight healthcare workers (3 doctors, 2 nurses, 2 personnel, and 1 security guard) began treatment for COVID‐19 as of May 15. Since COVID‐19 symptoms appeared between 10 and 11days after discharge, later than reported in several other studies, we can deduce that these patients had not been contaminated during their hospital stay. , , Considering a total of 453 healthcare employees in the obstetrics and gynecology department, an 8/453 (1.7%) disease prevalence is not comparable with the prevalence reported in Istanbul, the worst hit city by the pandemic. Preoperative COVID‐19 test results for both patients and health professionals are lacking in Turkey due to the fact that regular screening of preoperative patients and healthcare professionals for COVID‐19 is restricted by national regulations in the absence of suggestive symptoms. Surgical procedures performed within the aforementioned time were not all covered. We specifically performed surgeries for major gynecologic operations including malignant cases. On account of the fact that our hospital did not take on the duty of sharing the pandemic load of other institutions, these figures do not represent all gynecologic surgery cases and healthcare professionals’ COVID‐19 status during the pandemic period. Therefore, ongoing surgical procedures in multi‐disciplinary hospitals during the pandemic and their results need to be analyzed in a similar fashion to other published studies. The present study found that surgical operations could continue during the COVID‐19 pandemic in a specialty hospital (i.e. in a women’s and children's diseases hospital) that was not primarily serving as a pandemic hospital. This conclusion could possibly be extended to other specialty hospital settings. The prevalence of COVID‐19 in specialty hospitals could be lower than the regional prevalence; therefore, performing surgeries may be safer for both patients and healthcare providers in these specialty clinics.

AUTHOR CONTRIBUTIONS

SA, UKO, SEO performed the literature review. EK and UKO acquired the data. MA, SA, and EK designed the study. All authors contributed to drafting the manuscript critically for intellectual content, and approved the final version of the manuscript.

CONFLICTS OF INTEREST

The authors have no conflicts of interest.
  5 in total

1.  Cancer surgery during the Covid-19 pandemic in Turkey.

Authors:  Orhan Alimoglu; Cem Ilgin Erol; Furkan Kilic; Hakan Baysal
Journal:  Int J Surg       Date:  2020-05-19       Impact factor: 6.071

2.  Perspectives on Surgery in the Time of COVID-19: Safety First.

Authors:  Sarah L Cohen; Grace Liu; Mauricio Abrao; Neil Smart; Todd Heniford
Journal:  J Minim Invasive Gynecol       Date:  2020-04-03       Impact factor: 4.137

3.  Covid 19 pandemic and gynaecological laparoscopic surgery: knowns and unknowns.

Authors:  R Mallick; F Odejinmi; T J Clark
Journal:  Facts Views Vis Obgyn       Date:  2020-04-01

Review 4.  What Is the Appropriate Use of Laparoscopy over Open Procedures in the Current COVID-19 Climate?

Authors:  Yalini Vigneswaran; Vivek N Prachand; Mitchell C Posner; Jeffrey B Matthews; Mustafa Hussain
Journal:  J Gastrointest Surg       Date:  2020-04-13       Impact factor: 3.452

5.  Surgery in COVID-19 patients: operational directives.

Authors:  Federico Coccolini; Gennaro Perrone; Massimo Chiarugi; Francesco Di Marzo; Luca Ansaloni; Ildo Scandroglio; Pierluigi Marini; Mauro Zago; Paolo De Paolis; Francesco Forfori; Ferdinando Agresta; Alessandro Puzziello; Domenico D'Ugo; Elena Bignami; Valentina Bellini; Pietro Vitali; Flavia Petrini; Barbara Pifferi; Francesco Corradi; Antonio Tarasconi; Vittoria Pattonieri; Elena Bonati; Luigi Tritapepe; Vanni Agnoletti; Davide Corbella; Massimo Sartelli; Fausto Catena
Journal:  World J Emerg Surg       Date:  2020-04-07       Impact factor: 5.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.